BACE1 and Alzheimer disease: Moreover, NEAT1 has been suggested to function as a regulatory factor promoting AD development by modulating the miR-124/BACE1 axis; this pathway may be a potential novel therapeutic target for AD treatment (Zhao et al., 2019).